The Nervous System Has an Impact on Your Lipedema Inflammation

How 15 years of living with lipedema led me to stress, pain and the science of neuroimmune regulation

I was diagnosed with lipedema in 2012, when I was 20 years old. In many ways, I was lucky to get the diagnosis that early. We know that many women spend years trying to understand why their legs hurt, why they bruise so easily, or why their body seems to change differently from the people around them. I had a diagnosis relatively early, but I did not have much information about what to do with it.

“The vagus nerve is not the only connection between psychological state and immune function.”

The lipedema landscape was completely different then. I did not know anyone else with the condition, and social media was not filled with lipedema accounts telling me what to eat, which supplements to take, how to exercise, or which symptoms were supposedly caused by which mechanism. That was isolating, but looking back, I think there was also an advantage to it. I had to pay attention to my own body rather than learning what I was supposed to experience from other people.

I started recognizing patterns quite quickly. Hormones were already considered relevant to lipedema, and my GP changed my contraception to one without estrogen. I also noticed that refined sugar seemed to trigger my symptoms. I still have old messages to family and friends where I described these reactions, long before I knew whether anyone else with lipedema experienced the same thing. I did not have a theory about glucose, insulin, inflammation or adipose tissue. I simply knew that when I ate certain foods, my body sometimes felt different afterward.

Over the following years, stress became another pattern that was difficult for me to ignore. Some of the periods when my lipedema seemed to progress, and some of the periods when I experienced more symptoms, were also periods of considerable psychological stress. At other times, when I was sleeping well and life felt relatively calm, my body seemed less reactive. I could tolerate more, including some of the things I otherwise regarded as triggers.

I want to be careful with that observation because this is exactly where personal experience can easily become pseudoscience. I cannot look back at a stressful period of my life and know that my inflammatory cytokines increased. I cannot know whether stress caused my lipedema to progress, whether it increased pain without changing the underlying tissue, or whether several things were happening at the same time. Pain is not a measurement of inflammation, and feeling swollen or sensitive does not tell me what happened to IL-6, TNF-α or CRP.

What I can say is that stress has consistently mattered to how I experience my condition. It matters enough that today I consider stress management part of my own lipedema management, together with food, exercise, sleep and paying attention to hormonal changes. I have also changed what stress management means to me. It is less about doing a particular breathing exercise and more about how I structure my life.

“I did not know anyone else with the condition, and social media was not filled with lipedema accounts telling me what to eat, which supplements to take, how to exercise, or which symptoms were supposedly caused by which mechanism.”

I say no much more often than I used to. I pay attention to which people and activities leave me depleted and which give me energy. I care considerably less about satisfying other people’s expectations. If something repeatedly creates unnecessary stress, I am much more willing to remove myself from it rather than continually asking myself to cope better with it. LipedemaScience is an interesting example of the opposite. I can spend hours reading papers and working on this platform without experiencing it as draining. It gives me energy, and I want to keep it that way. I want LipedemaScience to fit into my life sustainably rather than becoming another source of chronic pressure.

For years, I did not have the scientific language for any of this. Now that “nervous system regulation” has become such a popular subject online, however, I wanted to understand whether there is actually biology behind what I have experienced. There is, but it is considerably more specific and considerably less magical than social media often makes it sound.

The nervous and immune systems are connected

The nervous system does not sit separately from the immune system. Communication between the two is a well-established area of physiology, and one of the best characterized examples is the inflammatory reflex and the cholinergic anti-inflammatory pathway associated particularly with the work of Kevin Tracey and colleagues.

Early experiments showed that electrical stimulation of the vagus nerve could inhibit production of pro-inflammatory cytokines, including TNF, during an inflammatory challenge. Subsequent research helped establish a more complicated neuroimmune circuit involving vagal signaling, the splenic nerve and immune cells. Acetylcholine signaling through the α7 nicotinic acetylcholine receptor is an important component of this pathway and can inhibit intracellular inflammatory signaling and cytokine production.

This work matters because it demonstrates something fundamental: neural activity can influence immune activity. The brain can receive information about inflammation, and neural circuits can participate in regulating the inflammatory response.

“I have also changed what stress management means to me.”

This is no longer purely animal physiology. Vagus nerve stimulation has subsequently been investigated in people with inflammatory diseases, including rheumatoid arthritis. Implantable devices provide controlled electrical stimulation to the vagus nerve, allowing researchers to test whether manipulating this pathway can influence inflammatory disease activity in humans.

But this is also where we need to make the first important distinction. Evidence that an implanted medical device delivering calibrated electrical impulses to the vagus nerve can influence an inflammatory pathway does not mean that meditation, slow breathing, cold exposure or a “vagus nerve exercise” has the same effect. The existence of the biological pathway establishes the mechanism. Each proposed method of manipulating that pathway still needs its own evidence.

Chronic stress can influence inflammatory regulation through another route

The vagus nerve is not the only connection between psychological state and immune function. Chronic stress also interacts with the immune system through the hypothalamic-pituitary-adrenal axis, or HPA axis.

“The nervous system becomes particularly relevant to lipedema when we move from inflammation to pain.”

Cortisol is often discussed online as though it were simply an inflammatory stress hormone that we should try to lower. Physiologically, that is an oversimplification. Cortisol is an important regulator of the immune response and normally has substantial anti-inflammatory activity. One of the more interesting findings from stress research is that prolonged psychological stress may alter how effectively immune cells respond to cortisol.

Research by Sheldon Cohen, Gregory Miller and colleagues has investigated what is often described as glucocorticoid resistance. With prolonged stress exposure, immune cells can become less sensitive to glucocorticoid signaling. The important consequence is not simply “more cortisol equals more inflammation.” Rather, one of the body’s mechanisms for controlling an inflammatory response may become less effective.

This relationship has been studied using experimental viral-challenge models, not simply questionnaires asking people whether they feel stressed. In these studies, participants were deliberately exposed to respiratory viruses and subsequently monitored. Chronic stress and impaired glucocorticoid sensitivity were associated with a less well-controlled inflammatory response.

This provides a biologically plausible explanation for something many people intuitively recognize: prolonged stress is not simply an unpleasant psychological experience. It can have physiological consequences. What it does not establish is that chronic stress specifically increases inflammation within lipedema tissue or causes lipedema to progress. We do not currently have the lipedema-specific experiments required to make that conclusion.

Lipedema adds another nervous-system question: pain

The nervous system becomes particularly relevant to lipedema when we move from inflammation to pain. Pain is one of the defining clinical characteristics of lipedema, yet the biological explanation for that pain remains incomplete.

Historically, several mechanisms have been proposed, including pressure within expanding tissue, altered microvasculature, inflammation and nerve abnormalities. Small-fiber neuropathy has also been discussed, although the evidence has not consistently supported it as the primary explanation. In 2017, Erich Brenner argued that the pain characteristics of lipedema were more compatible with mechanical allodynia involving Aβ fibers and potentially tactile C fibers than with direct small-fiber nerve damage.

More recent research has shifted some of the attention toward central pain processing. A case-control study published in Pain Medicine in September 2026 compared 59 women with lipedema with 59 age-matched healthy controls. The researchers assessed several dimensions of pain rather than simply asking whether participants experienced painful tissue. Women with lipedema had higher pain intensity and Central Sensitization Inventory scores, more neuropathic pain characteristics and lower pressure-pain thresholds.

This is important because central sensitization describes increased responsiveness within the central nervous system to sensory input. In practical terms, the nervous system can become more sensitive to signals arriving from the body, contributing to amplification or persistence of pain.

It is equally important not to reverse the direction of the evidence. These studies do not demonstrate that central sensitization causes lipedema. If painful peripheral tissue repeatedly sends nociceptive signals to the nervous system over many years, altered central pain processing could potentially develop as a consequence of persistent pain. Alternatively, differences in pain processing might contribute to the severity of symptoms. Both processes could also occur simultaneously.

We therefore have increasingly interesting evidence that the nervous system is involved in the experience and processing of lipedema pain. That is different from demonstrating that nervous-system dysfunction produces the abnormal adipose tissue, vascular changes or other underlying characteristics of lipedema.

What does this mean for inflammation in lipedema?

This is the point at which I think the language needs to become particularly careful.

There is good evidence that the nervous system can regulate inflammatory processes. There is evidence that chronic psychological stress can alter immune regulation. There is evidence connecting sleep disturbance with inflammatory markers such as CRP and IL-6. There is also emerging lipedema-specific evidence that pain processing may be altered.

What we do not yet have is a study showing that psychological stress increases inflammatory activity specifically within lipedema tissue. Nor do we have a clinical trial demonstrating that reducing stress or increasing vagal activity lowers lipedema-specific inflammation or slows progression of the disease.

Those missing experiments matter.

If I experience more pain during a stressful month, there are several possible explanations. Inflammatory signaling could have changed. My pain-processing system could have become more sensitive. Poorer sleep could have affected pain thresholds and immune function. My physical activity might have changed. Hormonal or metabolic factors might also be involved. Most likely, biology does not respect the neat categories we use to describe it, and several systems interact.

This is why I am comfortable saying that the nervous system matters to the inflammatory environment of the body, including in someone who happens to have lipedema, while remaining much more cautious about saying that “nervous-system dysregulation causes lipedema inflammation.” The first statement rests on established human physiology. The second requires lipedema-specific evidence that we do not yet have.

Can we actually change this through “nervous system regulation”?

One of the most interesting experiments in this area was published by Paul Lehrer and colleagues in 2010. Researchers induced a temporary inflammatory response in healthy volunteers using bacterial endotoxin and examined whether heart-rate-variability biofeedback could alter the response.

“There is good evidence that the nervous system can regulate inflammatory processes.“

The study was tiny, involving only 11 participants, but its findings are useful because they illustrate how easily different physiological outcomes can be confused. Participants trained in HRV biofeedback were better able to maintain heart-rate variability during the inflammatory challenge. In other words, they altered part of their autonomic response.

What they did not do was suppress the inflammatory cytokine response. The intervention affected autonomic physiology during experimentally induced inflammation, but the measured increase in pro-inflammatory cytokines remained.

That distinction is central to understanding the current evidence. Increasing HRV is not synonymous with reducing inflammation, and neither is synonymous with improving lipedema.

Another controlled study in young athletes provides a similarly useful caution. Focused breathing and HRV-biofeedback training did not produce the expected significant improvement in measured vagally mediated HRV. An intervention can make someone feel calmer or provide other psychological benefits without necessarily creating the physiological change that is being claimed for it.

Meditation and yoga have somewhat broader research literatures. Meta-analyses have reported changes in some inflammatory markers, particularly CRP, but results for IL-6, TNF-α and other cytokines are less consistent. Studies also differ substantially in population, duration, intervention and methodological quality. These practices may have value for stress, sleep, mobility, pain coping and quality of life without requiring us to claim that they are directly switching off inflammation through the vagus nerve.

Cold exposure is further down the evidence hierarchy. There are interesting experimental findings, including studies combining breathing, meditation and cold exposure, but the evidence is nowhere near sufficient to recommend cold exposure as a treatment for lipedema inflammation.

What I actually take from the science

After reading this literature, I have not changed my mind about stress being important in my own lipedema management. If anything, I take it more seriously. What has changed is how precisely I think about it.

I no longer need to explain every improvement I experience as “lower inflammation.” Stress can influence sleep, pain sensitivity, autonomic activity, endocrine signaling, immune regulation, food choices, movement and recovery. All of those can affect how I feel. Trying to reduce that entire network to a single cytokine or to the state of my vagus nerve probably makes the biology less accurate rather than more understandable.

It also changes what I prioritize. If the objective is to support health and reduce chronic inflammatory burden, some of the strongest evidence still belongs to interventions that are far less fashionable than nervous-system hacks: adequate sleep, regular physical activity, good metabolic health, nutritious food, avoiding smoking, and addressing persistent psychological stress when it becomes a problem. If meditation, slow breathing, yoga or HRV biofeedback helps someone sleep better, manage pain or reduce perceived stress, that can be valuable without pretending that we know it is reversing lipedema inflammation.

For me personally, stress management has become even broader than that. It means recognizing when something is repeatedly draining me and deciding whether it needs to remain in my life. It means not automatically saying yes. It means spending more of my time on work and people that give me something back. It means taking the signals from my body seriously without automatically assuming that I know the molecular explanation for them.

In some ways, that takes me back to being 20 years old in 2012. I did not have a community, an algorithm or a list of recommended lipedema protocols. I had a diagnosis and a body that was giving me information. Over the following 15 years, I learned to pay attention to that information.

Today we have something I did not have then: a rapidly expanding scientific literature and a community capable of sharing it almost immediately. That is an enormous advantage, provided we do not allow the amount of information available to create more certainty than the research justifies.

My own experience tells me that stress matters to my lipedema. Science tells me there are credible biological reasons why stress, the nervous system, immune regulation and pain can interact. Emerging lipedema research tells us that altered pain processing may be part of the condition’s symptom biology.

The part that remains unknown is just as important. We cannot yet say that nervous-system dysregulation causes lipedema, that stress directly drives inflammation in lipedema tissue, or that “regulating” the nervous system can stop disease progression.

For me, that uncertainty does not make stress management less important. It simply means I can listen to what my body has been telling me for 15 years without turning my personal experience into a mechanism that science has not yet demonstrated.